BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33500829
Number of visits today
6438
Number of downloads
16686397
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Gao H, Lou S, Hong H, Ge Q, Zhao H. Autophagy Inhibition Potentiates the Anticancer Effects of a Bendamustine Derivative NL-101 in Acute T Lymphocytic Leukemia. Biomed Res Int 2020;2020:1520651. [PMID: 32149078 DOI: 10.1155/2020/1520651] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Huang FL, Yu SJ, Li CL. Role of Autophagy and Apoptosis in Acute Lymphoblastic Leukemia. Cancer Control 2021;28:10732748211019138. [PMID: 34169775 DOI: 10.1177/10732748211019138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Molina MS, Hoffman EA, Stokes J, Kummet N, Smith KA, Baker F, Zúñiga TM, Simpson RJ, Katsanis E. Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death. Front Immunol 2021;12:699128. [PMID: 34249005 DOI: 10.3389/fimmu.2021.699128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Chen M, Dong X, Deng H, Ye F, Zhao Y, Cheng J, Dan G, Zhao J, Sai Y, Bian X, Zou Z. Targeting TRPV1-mediated autophagy attenuates nitrogen mustard-induced dermal toxicity. Signal Transduct Target Ther 2021;6:29. [PMID: 33487631 DOI: 10.1038/s41392-020-00389-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
4 Liu W, Liang Y, Si X. Hydroxamic acid hybrids as the potential anticancer agents: An Overview. European Journal of Medicinal Chemistry 2020;205:112679. [DOI: 10.1016/j.ejmech.2020.112679] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345